Acceptability of neural stem cell therapy for cerebral palsy: survey of the Australian cerebral palsy community.

ABSTRACT:

Background

Neural stem cells (NSCs) have the potential to engraft and replace damaged brain tissue, repairing the damaged neonatal brain that causes cerebral palsy (CP). There are procedures that could increase engraftment of NSCs and may be critical for efficacy, but hold notable risks. Before clinical trials progress, it is important to engage with the CP community to understand their opinions. The aim of this study was to determine the acceptability of NSC therapy for CP in the CP community.

Methods

Australian residents with CP and parents/carers of those with CP completed a questionnaire to determine their willingness to use NSCs from three sources (fetal, embryonic and induced pluripotent stem cells) and their willingness to undergo accompanying procedures (neurosurgery

SUBMITTER: Smith MJ 

PROVIDER: S-EPMC9898914 | biostudies-literature | 2023 Feb

REPOSITORIES: biostudies-literature